ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s account receivable for the three months ended in Jun. 2013 was $131.3 Mil. Onyx Pharmaceuticals, Inc.'s revenue for the three months ended in Jun. 2013 was $153.0 Mil. Hence, Onyx Pharmaceuticals, Inc.'s days sales outstanding for the three months ended in Jun. 2013 was 78.30.
Onyx Pharmaceuticals, Inc.'s days sales outstanding increased from Jun. 2012 (77.47) to Jun. 2013 (78.30).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Onyx Pharmaceuticals, Inc.'s Days Sales Outstanding for the fiscal year that ended in Dec. 2012 is calculated as
Onyx Pharmaceuticals, Inc.'s Days Sales Outstanding for the quarter that ended in Jun. 2013 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data